Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus.

Glampedakis E, Coste AT, Aruanno M, Bachmann D, Delarze E, Erard V, Lamoth F.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01137-18. doi: 10.1128/AAC.01137-18. Print 2018 Dec.

PMID:
30323034
2.

Implications of the EUCAST Trailing Phenomenon in Candida tropicalis for the In Vivo Susceptibility in Invertebrate and Murine Models.

Astvad KMT, Sanglard D, Delarze E, Hare RK, Arendrup MC.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01624-18. doi: 10.1128/AAC.01624-18. Print 2018 Dec.

PMID:
30224538
3.

Defining the frontiers between antifungal resistance, tolerance and the concept of persistence.

Delarze E, Sanglard D.

Drug Resist Updat. 2015 Nov;23:12-19. doi: 10.1016/j.drup.2015.10.001. Epub 2015 Oct 30. Review.

PMID:
26690338
4.

Adaptation of a Gaussia princeps Luciferase reporter system in Candida albicans for in vivo detection in the Galleria mellonella infection model.

Delarze E, Ischer F, Sanglard D, Coste AT.

Virulence. 2015;6(7):684-93. doi: 10.1080/21505594.2015.1081330.

5.

Examining the virulence of Candida albicans transcription factor mutants using Galleria mellonella and mouse infection models.

Amorim-Vaz S, Delarze E, Ischer F, Sanglard D, Coste AT.

Front Microbiol. 2015 May 5;6:367. doi: 10.3389/fmicb.2015.00367. eCollection 2015.

Supplemental Content

Loading ...
Support Center